Source:http://linkedlifedata.com/resource/pubmed/id/14743006
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-1-26
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0041-1337
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
323-4
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14743006-Complement C2,
pubmed-meshheading:14743006-Cyclosporine,
pubmed-meshheading:14743006-Graft Rejection,
pubmed-meshheading:14743006-Humans,
pubmed-meshheading:14743006-Immunosuppressive Agents,
pubmed-meshheading:14743006-Kidney Transplantation,
pubmed-meshheading:14743006-Monitoring, Physiologic
|
pubmed:year |
2004
|
pubmed:articleTitle |
Patient management by cyclosporine C2 monitoring.
|
pubmed:publicationType |
Letter,
Comment
|